Yoichi Osako
Overview
Explore the profile of Yoichi Osako including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sakaguchi T, Osako Y, Mitsuke A, Ogawa R, Takeyama H, Matsushita R, et al.
Urol Case Rep
. 2025 Feb;
59:102935.
PMID: 39897998
We report our experience with a pregnant patient with a giant calyceal diverticulum-a very rare presentation. A 30-year-old pregnant woman was referred to our department with left flank pain at...
2.
Sakaguchi T, Mitsuke A, Osako Y, Yamada Y, Takeyama H, Ogawa R, et al.
BMC Nephrol
. 2024 Apr;
25(1):124.
PMID: 38589827
Background: Kidney transplant recipients (KTRs) are at risk of severe coronavirus disease 2019 (COVID-19), and even now that Omicron subvariants have become dominant, cases of severe disease are certain to...
3.
Mitsuke A, Ohbo T, Arima J, Osako Y, Sakaguchi T, Matsushita R, et al.
PLoS One
. 2023 Oct;
18(10):e0287059.
PMID: 37819994
The development of diabetes mellitus (DM) after living donor kidney transplantation (KT) is a risk factor for worsening transplant kidney function, cardiac disease, and cerebrovascular disease, which may affect prognosis...
4.
Yoshino H, Yokoyama S, Tamai M, Okamura S, Iizasa S, Sakaguchi T, et al.
FEBS Open Bio
. 2023 Apr;
13(6):1056-1066.
PMID: 37079001
Combination chemotherapy with gemcitabine and cisplatin (GC) is recommended as the primary treatment for advanced bladder cancer (BC). However, the benefits of this approach are limited owing to the acquisition...
5.
Kawakami I, Yoshino H, Fukumoto W, Tamai M, Okamura S, Osako Y, et al.
Biochem Biophys Res Commun
. 2022 Apr;
611:99-106.
PMID: 35487063
In recent years, cancer metabolism has attracted attention as a therapeutic target, and glutamine metabolism is considered one of the most important metabolic processes in cancer. Solute carrier family 1...
6.
Tamai M, Tatarano S, Okamura S, Fukumoto W, Kawakami I, Osako Y, et al.
Mol Oncol
. 2022 Feb;
16(6):1329-1346.
PMID: 35148461
Patients with advanced bladder cancer are generally treated with a combination of chemotherapeutics, including gemcitabine, but the effect is limited due to acquisition of drug resistance. Thus, in this study,...
7.
Kawahira H, Fujii K, Yonezawa T, Osako Y, Kanekura T
J Dermatol
. 2021 Oct;
49(1):e20-e21.
PMID: 34637157
No abstract available.
8.
Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, et al.
BMC Cancer
. 2021 Jan;
21(1):48.
PMID: 33430801
Background: Cisplatin-based chemotherapy is recommended as the primary treatment for advanced bladder cancer (BC) with unresectable or metastatic disease. However, the benefits are limited due to the acquisition of drug...
9.
Yoshino H, Yamada Y, Enokida H, Osako Y, Tsuruda M, Kuroshima K, et al.
PLoS One
. 2020 Jul;
15(7):e0236119.
PMID: 32667929
The alcohol-abuse drug disulfiram has antitumor effects against diverse cancer types via inhibition of the ubiquitin-proteasome protein nuclear protein localization protein 4 (NPL4). However, the antitumor effects of NPL4 and...
10.
Yoshino H, Enokida H, Osako Y, Nohata N, Yonemori M, Sugita S, et al.
Mol Oncol
. 2020 May;
14(9):2190-2202.
PMID: 32386122
d-3-Phosphoglycerate dehydrogenase (PHGDH) conducts an important step in the synthesis of serine. Importantly, the PHGDH gene is often amplified in certain cancers. Our previous studies revealed that PHGDH gene amplification...